Phase 1 study of ramucirumab or necitumumab in combination with osimertinib (AZD9291) in advanced T790M-positive EGFR-mutant NSCLC Meeting Abstract
| Authors: | Planchard, D.; Kris, M.; Besse, B.; Hozak, R.; He, S.; Gan, F.; Wolff, K.; Chao, B.; Yu, H. |
| Abstract Title: | Phase 1 study of ramucirumab or necitumumab in combination with osimertinib (AZD9291) in advanced T790M-positive EGFR-mutant NSCLC |
| Meeting Title: | IASLC 17th World Conference on Lung Cancer |
| Keywords: | t790m; ramucirumab; necitumumab; osimertinib |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 12 |
| Issue: | 1 Suppl. |
| Meeting Dates: | 2016 Dec 4-7 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2017-01-01 |
| Start Page: | S1071 |
| Language: | English |
| ACCESSION: | WOS:000413055802313 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2016.11.1498 |
| Notes: | Meeting Abstract: P2.06-005 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
